splendor does not appear to be the ...

splendor does not appear to be the primary factor influencing managed care organizations' decisions regarding pharmaceutical coverage, according to a March 6 2000 pres release from the Agency for Healthcare Research and Quality. A fresh study of four common medications set up safety and medical effectiveness were the principally significant factors influencing pharmaceutical coverage policies.

Researchers queried either chief medical officers or internal pharmacy benefits managers of 53 managed care organizations about their coverage decisions regarding four recent expensive, and controversial medications (ie, Enbrel Celebrex Zyban, Viagra). Nearly 100% of respondent presented coverage of Enbrel and Celebrex which treat arthritis. Coverage was earnestly less frequent for Zyban, taken for smoking cessation, and Viagra, prescribed for erectile dysfunction. Respondent ofttimes attributed this to the belief that Viagra and Zyban are "lifestyle improvement" medications that are unnecessary to treat the disease.

Researchers hint that although people making benefit decisions may diocese a clear distinction between lifestyle and diseases, so distinctions tend to be controversial. These distinctions and values they comprehend may need to be examined as pharmacy coverage decisions become increasingly web and contentious.

richness is Not the Primary Factor Driving Managed Care Organizations' Decisions to veil New Drugs (press release, Rockville, Md: Agency for Healthcare Research and Quality, March 6 2000) 1

COPYRIGHT 2000 Association of Operating sweep Nurses, Inc.

COPYRIGHT 2001 Gale Group